AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27485469 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week maximal-intensity isometric training of the right first dorsal interosseus muscle through key pinching
Number of subjects: 34
Study 27485469 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34
Study 24894416 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 65
Study 24894416 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment (non-SSRIs)
Number of subjects: 65
Study 24894416 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 65
Study 22245692 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual counselling group (every six weeks) + optional series of 25 group seminars (every week)
Number of subjects: 48
Study 22245692 — intervention group
Group type: COMPARATOR
Intervention: Group seminars only
Number of subjects: 48
Study 20606431 — intervention group
Group type: EXPERIMENTAL
Intervention: Duraphat 5,000 ppm F
Number of subjects: 211
Study 20606431 — intervention group
Group type: COMPARATOR
Intervention: Pepsodent Superfluor 1,450 ppm F
Number of subjects: 211
Study 17651380 — intervention group
Group type: EXPERIMENTAL
Intervention: Active ASIT with Alternaria alternata extract
Number of subjects: 28
Study 17651380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 16580957 — intervention group
Group type: EXPERIMENTAL
Intervention: Gated FDG-PET with FDG uptake of 50% or greater
Number of subjects: 38
Study 16580957 — intervention group
Group type: EXPERIMENTAL
Intervention: Gated FDG-PET with wall thickening (WT) of 10% or greater
Number of subjects: 38
Study 16580957 — intervention group
Group type: EXPERIMENTAL
Intervention: Gated FDG-PET with WT of 10% or greater
Number of subjects: 38
Study 16580957 — intervention group
Group type: COMPARATOR
Intervention: Magnetic resonance imaging before and 6 months after revascularization
Number of subjects: 38
Study 14557006 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 49
Study 14557006 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular insulin
Number of subjects: 49
Study 14557006 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-diabetic pregnant women)
Number of subjects: 49
Study 10881265 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetization transfer ratio (MTR)
Number of subjects: 21
Study 10881265 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean diffusivity (D) histogram peak heights
Number of subjects: 21
Study 8822674 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheelchair users
Number of subjects: 8
Study 8822674 — intervention group
Group type: COMPARATOR
Intervention: Nondisabled individuals
Number of subjects: 8
Study 1460149 — intervention group
Group type: EXPERIMENTAL
Intervention: Various forms of treatment for depression
Number of subjects: 0
Study 1460149 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of depression
Number of subjects: 0
Study 1460149 — intervention group
Group type: COMPARATOR
Intervention: Specific types of personality disorders
Number of subjects: 0
Study 6376207 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg/triamterene 50 mg
Number of subjects: 0
Study 6376207 — intervention group
Group type: COMPARATOR
Intervention: Chlorthalidone 25 mg
Number of subjects: 0
Study 31444995 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined longer telomere length
Number of subjects: 261837
Study 29374734 — intervention group
Group type: EXPERIMENTAL
Intervention: 5×4Gy
Number of subjects: 203
Study 29374734 — intervention group
Group type: COMPARATOR
Intervention: 10×3Gy
Number of subjects: 203
Study 26443018 — intervention group
Group type: EXPERIMENTAL
Intervention: Air stacking via home ventilator
Number of subjects: 52
Study 26443018 — intervention group
Group type: COMPARATOR
Intervention: Air stacking via resuscitator bag
Number of subjects: 52
Study 26443018 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods (home ventilator and resuscitator bag)
Number of subjects: 52
Study 24212255 — intervention group
Group type: EXPERIMENTAL
Intervention: Lokomat(®) experimental gait training (LE)
Number of subjects: 26
Study 24212255 — intervention group
Group type: COMPARATOR
Intervention: Lokomat(®) conventional gait training (LC)
Number of subjects: 26
Study 22173953 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS
Number of subjects: 30
Study 22173953 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 30
Study 19906829 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based early intervention
Number of subjects: 56
Study 19906829 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study 18072061 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow Band Imaging (NBI) with magnification
Number of subjects: 99
Study 18072061 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnifying Chromoendoscopy
Number of subjects: 99
Study 15661601 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet one-item mode
Number of subjects: 591
Study 15661601 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet mode
Number of subjects: 591
Study 15661601 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet multiple items per screen format
Number of subjects: 591
Study 15661601 — intervention group
Group type: COMPARATOR
Intervention: Paper and pencil (P&P) mode
Number of subjects: 591
Study 11854728 — intervention group
Group type: EXPERIMENTAL
Intervention: Spliced vein bypass grafting
Number of subjects: 36
Study 11854728 — intervention group
Group type: COMPARATOR
Intervention: Polytetrafluoroethylene grafting with a distal vein cuff
Number of subjects: 36
Study 10395628 — intervention group
Group type: EXPERIMENTAL
Intervention: Live-culture yogurt (200 g/d for 1 year)
Number of subjects: 3
Study 10395628 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasteurized yogurt (200 g/d for 1 year)
Number of subjects: 3
Study 10395628 — intervention group
Group type: COMPARATOR
Intervention: Control (no yogurt)
Number of subjects: 3
Study 7550527 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP; ‐15 mmHg) after glucose ingestion
Number of subjects: 8
Study 7550527 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP; ‐15 mmHg) in the postabsorptive state
Number of subjects: 8
Study 2160356 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical score
Number of subjects: 160
Study 2160356 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma parathyroid hormone
Number of subjects: 160
Study 2160356 — intervention group
Group type: EXPERIMENTAL
Intervention: Discriminant function based on parathyroid hormone and alkaline phosphatase
Number of subjects: 160
Study 2160356 — intervention group
Group type: EXPERIMENTAL
Intervention: Discriminant function utilizing calcium, phosphate and alkaline phosphatase
Number of subjects: 160
Study 2160356 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma 25-hydroxy-vitamin D
Number of subjects: 160
Study 2160356 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical score with abnormal results
Number of subjects: 160
Study 6941657 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in lifestyle (increased physical activity, decreased fat and salt intake)
Number of subjects: 928
Study 6941657 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lifestyle change)
Number of subjects: 928
Study 29880065 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive Counseling (SC)
Number of subjects: 246
Study 29880065 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-Behavioral Coping and Communication (CCI)
Number of subjects: 246
Study 27914670 — intervention group
Group type: EXPERIMENTAL
Intervention: Corega denture adhesive
Number of subjects: 34
Study 27914670 — intervention group
Group type: EXPERIMENTAL
Intervention: Fittydent denture adhesive
Number of subjects: 34
Study 27914670 — intervention group
Group type: COMPARATOR
Intervention: No denture adhesive
Number of subjects: 34
Study 27914670 — intervention group
Group type: COMPARATOR
Intervention: Dentate control group
Number of subjects: 34
Study 25369827 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (5 × 10(9) CFUs; twice daily)
Number of subjects: 60
Study 25369827 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice daily)
Number of subjects: 60
Study 25369827 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 60
Study 25369827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 24524339 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine
Number of subjects: 223
Study 24524339 — intervention group
Group type: COMPARATOR
Intervention: Fludarabine
Number of subjects: 223
Study 24524339 — intervention group
Group type: COMPARATOR
Intervention: Chlorambucil
Number of subjects: 223
Study 22901562 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol (250 mg/d) along with oral hypoglycemic agents
Number of subjects: 62
Study 22901562 — intervention group
Group type: COMPARATOR
Intervention: Oral hypoglycemic agents only
Number of subjects: 62
Study 19968378 — intervention group
Group type: EXPERIMENTAL
Intervention: Family cognitive-behavioral preventive intervention
Number of subjects: 111
Study 19968378 — intervention group
Group type: COMPARATOR
Intervention: Self-study written information condition (Control)
Number of subjects: 111
Study 17675054 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan (10-minute bolus 12 microg/kg, followed by 0.1 microg/kg/min for 24 hours)
Number of subjects: 40
Study 17675054 — intervention group
Group type: COMPARATOR
Intervention: Control (no levosimendan)
Number of subjects: 40
Study 15146566 — intervention group
Group type: COMPARATOR
Intervention: CBE (Control arm)
Number of subjects: 0
Study 15146566 — intervention group
Group type: EXPERIMENTAL
Intervention: CBE supplemented with mammography (Study arm)
Number of subjects: 0
Study 11328262 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (400 mg b.d.)
Number of subjects: 0
Study 11328262 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (400 mg b.d.) + Vitamin C (480 mg b.d.)
Number of subjects: 0
Study 9877109 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium infusion rate varied to produce a fall of at least 0.2 mmol/l in ionized calcium during hemodialysis.
Number of subjects: 2
Study 9877109 — intervention group
Group type: COMPARATOR
Intervention: Calcium infusion rate maintained stable ionized calcium during hemodialysis.
Number of subjects: 2
Study 8033617 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR-based method for detecting HPV DNA
Number of subjects: 616
Study 8033617 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC method for detecting HPV-Ag
Number of subjects: 616
Study 8033617 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopy for detecting koilocytes
Number of subjects: 616
Study 8033617 — intervention group
Group type: EXPERIMENTAL
Intervention: Electron microscopy for detecting HPV particles
Number of subjects: 616
Study 8033617 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up observation for 3 months to 2 years
Number of subjects: 616
Study 2916485 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (HPD)
Number of subjects: 5
Study 2916485 — intervention group
Group type: COMPARATOR
Intervention: Low-protein diet (LPD)
Number of subjects: 5
Study 172181 — intervention group
Group type: EXPERIMENTAL
Intervention: Equine ('natural') oestrogens for three months followed by placebo for three months
Number of subjects: 30
Study 172181 — intervention group
Group type: COMPARATOR
Intervention: Placebo for three months followed by equine ('natural') oestrogens for three months
Number of subjects: 30
Study 172181 — intervention group
Group type: EXPERIMENTAL
Intervention: Equine ('natural') oestrogens
Number of subjects: 30
Study 172181 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural oestrogen administration
Number of subjects: 30
Study 172181 — intervention group
Group type: COMPARATOR
Intervention: Synthetic oestrogen administration with oral contraception
Number of subjects: 30
Study 31519668 — intervention group
Group type: EXPERIMENTAL
Intervention: Conscious Sedation (CS)
Number of subjects: 270
Study 31519668 — intervention group
Group type: COMPARATOR
Intervention: General Anaesthesia (GA)
Number of subjects: 270
Study 28395750 — intervention group
Group type: EXPERIMENTAL
Intervention: Selamectin plus sarolaner (Stronghold® Plus, Zoetis)
Number of subjects: 277
Study 28395750 — intervention group
Group type: COMPARATOR
Intervention: Imidacloprid plus moxidectin (Advocate® for Cats, Bayer)
Number of subjects: 277
Study 28395750 — intervention group
Group type: COMPARATOR
Intervention: Fipronil (Frontline® Spot on, Merial)
Number of subjects: 277
Study 25761850 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation training (4 one-on-one, 15-minute sessions over 4 months)
Number of subjects: 29
Study 23388004 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% paromomycin-0.5% gentamicin
Number of subjects: 375
Study 21656715 — intervention group
Group type: EXPERIMENTAL
Intervention: Subfascial endoscopic perforator surgery (SEPS)
Number of subjects: 75
Study 21656715 — intervention group
Group type: COMPARATOR
Intervention: Saphenous surgery alone
Number of subjects: 75
Study 19168107 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA vaccine (intramuscularly or intradermally)
Number of subjects: 0
Study 19168107 — intervention group
Group type: COMPARATOR
Intervention: Control (Towne only)
Number of subjects: 0
Study 16505513 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-s maximal cycling sprint
Number of subjects: 7
Study 16505513 — intervention group
Group type: COMPARATOR
Intervention: Rest (control trial)
Number of subjects: 7
Study 15285057 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 ml of Iohexol 300
Number of subjects: 100
Study 15285057 — intervention group
Group type: COMPARATOR
Intervention: 75 ml of Ioversol 320
Number of subjects: 100
Study 11227031 — intervention group
Group type: EXPERIMENTAL
Intervention: Potato dumplings (165g)
Number of subjects: 17
Study 11227031 — intervention group
Group type: COMPARATOR
Intervention: White bread (90g)
Number of subjects: 17
Study 11227031 — intervention group
Group type: EXPERIMENTAL
Intervention: Pizza (equivalent carbohydrate amount)
Number of subjects: 17
Study 11227031 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard toasted bread (equivalent carbohydrate amount)
Number of subjects: 17
Study 9630829 — intervention group
Group type: EXPERIMENTAL
Intervention: OPC‐31260 (30 mg, orally)
Number of subjects: 8
Study 9630829 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (n=6)
Number of subjects: 8
Study 7946238 — intervention group
Group type: EXPERIMENTAL
Intervention: Family intervention (experimental group)
Number of subjects: 78
Study 7946238 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular use of medication with family intervention
Number of subjects: 78
Study 7946238 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 78
Study 2438755 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete transurethral adenomectomy of the prostate
Number of subjects: 167
Study 2438755 — intervention group
Group type: COMPARATOR
Intervention: Less extensive resection
Number of subjects: 167
Study 2438755 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative urethral instrumentation
Number of subjects: 167
Study 29686759 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Cycle Deliberate Practice (RCDP)
Number of subjects: 38
Study 29686759 — intervention group
Group type: COMPARATOR
Intervention: Traditional simulation debriefing
Number of subjects: 38
Study 29932590 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase I intervention (14 classes, 60 minutes each, starting during pregnancy)
Number of subjects: 100
Study 29932590 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase II intervention (3 monthly classes, 60 minutes each, postpartum)
Number of subjects: 100
Study 25495754 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh-squeezed orange juice (FOJ)
Number of subjects: 0
Study 25495754 — intervention group
Group type: COMPARATOR
Intervention: Commercially processed orange juice (POJ)
Number of subjects: 0
Study 22795420 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compressions performed on the floor
Number of subjects: 74
Study 22795420 — intervention group
Group type: COMPARATOR
Intervention: Chest compressions performed on a stretcher
Number of subjects: 74
Study 22795420 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants trained within a year performing on the floor
Number of subjects: 74
Study 22795420 — intervention group
Group type: COMPARATOR
Intervention: Participants trained within a year performing on a stretcher
Number of subjects: 74
Study 22795420 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants trained over a year ago performing on the floor
Number of subjects: 74
Study 22795420 — intervention group
Group type: COMPARATOR
Intervention: Participants trained over a year ago performing on a stretcher
Number of subjects: 74
Study 20026575 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment group intervention (six, 2-hour group treatment sessions)
Number of subjects: 40
Study 20026575 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 40
Study 18656721 — intervention group
Group type: EXPERIMENTAL
Intervention: Sialodochoplasty (n = 28)
Number of subjects: 59
Study 18656721 — intervention group
Group type: COMPARATOR
Intervention: No sialodochoplasty (n = 26)
Number of subjects: 59
Study 18656721 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful stone removal
Number of subjects: 59
Study 16402638 — intervention group
Group type: EXPERIMENTAL
Intervention: Diseased sinus
Number of subjects: 49
Study 16402638 — intervention group
Group type: COMPARATOR
Intervention: Control sinus
Number of subjects: 49
Study 12810245 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with pioglitazone (30 mg/day) plus metformin
Number of subjects: 0
Study 12810245 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with pioglitazone (15 or 30 mg/day) plus sulfonylurea
Number of subjects: 0
Study 11080699 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance of indoor allergens
Number of subjects: 0
Study 11080699 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical and chemical measures targeting house dust mite, pet, and cockroach allergens
Number of subjects: 0
Study 11080699 — intervention group
Group type: EXPERIMENTAL
Intervention: Education of allergic patients
Number of subjects: 0
Study 9148020 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of anti-neutrophil cytoplasmic antibodies (ANCA)
Number of subjects: 32
Study 9148020 — intervention group
Group type: EXPERIMENTAL
Intervention: C-ANCA pattern
Number of subjects: 32
Study 9148020 — intervention group
Group type: EXPERIMENTAL
Intervention: P-ANCA pattern
Number of subjects: 32
Study 9148020 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of actin as a target antigen
Number of subjects: 32
Study 9148020 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorption of sera with actin
Number of subjects: 32
Study 9148020 — intervention group
Group type: EXPERIMENTAL
Intervention: Western Blot analysis with actin
Number of subjects: 32
Study 9148020 — intervention group
Group type: EXPERIMENTAL
Intervention: Actin-ELISA
Number of subjects: 32
Study 8342184 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose acetylsalicylic acid (ASA) 75 mg/d for 6 months
Number of subjects: 232
Study 8342184 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical tablets)
Number of subjects: 232
Study 3538957 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitored group (theophylline dosages adjusted daily based on estimated clearance)
Number of subjects: 91
Study 3538957 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitored group
Number of subjects: 91
Study 3538957 — intervention group
Group type: COMPARATOR
Intervention: Control group (dosages determined by attending physicians)
Number of subjects: 91
Study 31581836 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter message
Number of subjects: 6896
Study 31581836 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer message
Number of subjects: 6896
Study 31581836 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recruitment through patient portal messages
Number of subjects: 6896
Study 29170266 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 206
Study 29170266 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 206
Study 27462118 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous albumin 25% at 2 g/kg
Number of subjects: 0
Study 27462118 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study 24766978 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe prescriptions in the US
Number of subjects: 100000
Study 24766978 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe prescriptions in Canada
Number of subjects: 100000
Study 24365167 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HES 130/0.4 plus lactated Ringer's solution
Number of subjects: 48
Study 24365167 — intervention group
Group type: COMPARATOR
Intervention: lactated Ringer's solution
Number of subjects: 48
Study 21340381 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon aminocaproic acid (EACA) - 25 grams total infused during surgery
Number of subjects: 42
Study 21340381 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline solution)
Number of subjects: 42
Study 18180340 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (400 mg/d)
Number of subjects: 175
Study 18180340 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study 16822122 — intervention group
Group type: EXPERIMENTAL
Intervention: Task confusion errors
Number of subjects: 0
Study 16822122 — intervention group
Group type: EXPERIMENTAL
Intervention: Error detection
Number of subjects: 0
Study 16822122 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterror processes implying error correction response
Number of subjects: 0
Study 12608556 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow at 200 ml/min
Number of subjects: 13
Study 12608556 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow at 250 ml/min
Number of subjects: 13
Study 12608556 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow at 300 ml/min
Number of subjects: 13